ADCT News and Press, ADC Therapeutics SA From 11/10/25

ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update PR Newswire Continued progress across LOTIS-7 with updated data anticipated in 2025 and LOTIS-5 with topline data expected in 1H 2026 Updated data from Phase 2 IIT of ZYNLONTA ...

VEON Ltd. (VEON) is expected to report $1.21 for Q3 2025 eToro Group Ltd. (ETOR) is expected to report $0.52 for Q3 2025 KE Holdings Inc American Depositary Shares (each representing three Class A) (BEKE) is expected to report $0.09 for Q3 2025 CoreWeave Inc. (CRWV) is expected to rep...

2025-11-07 12:01:09 ET More on ADC Therapeutics ADC Therapeutics SA 2025 Q2 - Results - Earnings Call Presentation ADC Therapeutics SA (ADCT) Q2 2025 Earnings Call Transcript ADC Therapeutics rises on $60M PIPE financing ADC Therapeutics targets $600M–...

ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025 PR Newswire LAUSANNE , Switzerland , Nov. 3, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug c...

2025-10-13 07:50:48 ET More on ADC Therapeutics ADC Therapeutics SA 2025 Q2 - Results - Earnings Call Presentation ADC Therapeutics SA (ADCT) Q2 2025 Earnings Call Transcript ADC Therapeutics targets $600M–$1B peak revenue potential for ZYNLONTA amid strategic...

ADC Therapeutics Announces $60 Million Private Placement PR Newswire LAUSANNE , Switzerland , Oct. 13, 2025 /PRNewswire/ --  ADC Therapeutics SA  (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today annou...

ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025 PR Newswire LAUSANNE , Switzerland , Aug. 27, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjuga...

2025-08-12 11:29:24 ET More on ADC Therapeutics ADC Therapeutics SA 2025 Q2 - Results - Earnings Call Presentation ADC Therapeutics SA (ADCT) Q2 2025 Earnings Call Transcript ADC Therapeutics SA (ADCT) Q1 2025 Earnings Call Transcript ADC reports data from ly...

2025-08-12 11:27:54 ET ADC Therapeutics SA (ADCT) Q2 2025 Earnings Conference Call August 12 2025, 08:30 AM ET Company Participants Ameet Mallik - CEO & Director Jose I. Carmona - Chief Financial Officer Mohamed Zaki - Chief Medical Officer Nicole Riley -...

2025-08-12 07:34:06 ET More on ADC Therapeutics ADC Therapeutics SA (ADCT) Q1 2025 Earnings Call Transcript ADC Therapeutics SA 2025 Q1 - Results - Earnings Call Presentation ADC reports data from lymphoma trial, streamlines operations ADC Therapeutics announ...